Diisobutyl ketone (DIBK) is a colorless liquid with a characteristic ketone odor. It is a common solvent and is used in the production of various chemicals, including paints, resins, and pesticides. DIBK is typically synthesized through the aldol condensation of isobutyraldehyde, followed by dehydration and hydrogenation. Its high volatility and solubility make it a suitable solvent for a wide range of applications. While DIBK is generally considered safe, it can be irritating to the skin and eyes and should be handled with caution. DIBK is also a common component in some types of industrial wastewater, requiring proper treatment methods to prevent environmental contamination. Research on DIBK focuses on its use as a solvent, its environmental impact, and its potential for use in new chemical processes.'
ID Source | ID |
---|---|
PubMed CID | 7958 |
CHEMBL ID | 3182186 |
CHEBI ID | 89195 |
SCHEMBL ID | 36990 |
MeSH ID | M0154603 |
Synonym |
---|
diisobutylketon(dutch, german) |
nsc15136 |
nsc-15136 |
2,6-dimetil-eptan-4-one |
s-diisopropylacetone |
di-isobutylcetone |
2, german) |
diisobutilchetone |
dibk |
4-heptanone,6-dimethyl- |
isovalerone |
isobutyl ketone |
2,6-dimethylheptan-4-one |
108-83-8 |
diisobutyl ketone |
2,6-dimethyl-4-heptanone |
wln: 1y1 & 1v1y1 & 1 |
4-heptanone, 2,6-dimethyl- |
inchi=1/c9h18o/c1-7(2)5-9(10)6-8(3)4/h7-8h,5-6h2,1-4h |
4-heptanone,2,6-dimethyl diisobutyl,ketone |
nsc406913 |
nsc-406913 |
nsc 15136 |
sec-diisopropyl acetone |
ccris 6233 |
di-isobutylcetone [french] |
2,6-dimethyl-heptan-4-on [dutch, german] |
hsdb 527 |
heptanone, 2,6-dimethyl-, 4- |
2,6-dimethylheptanone |
diisobutylketon [dutch, german] |
diisobutilchetone [italian] |
diisobutyl ketone [un1157] [flammable liquid] |
brn 1743163 |
2,6-dimethyl-4-heptanone (natural) |
sym-diisopropylacetone |
un1157 |
2,6-dimethyl-heptan-4-on [dutch,german] |
ai3-11270 |
2,6-dimetil-eptan-4-one [italian] |
einecs 203-620-1 |
fema no. 3537 |
caswell no. 355b |
2,6-dimethyl-4-heptanone, >=99% |
2,6-dimethyl-4-heptanone, technical grade |
2,6-dimethyl-4-heptanone, 99% |
2,6-dimethyl-4-heptanone, technical grade, 80% |
valerone |
diisobutylketone |
D0733 |
2,6-dimethyl-heptan-4-on |
68514-40-9 |
A801931 |
NCGC00249221-01 |
diisobutyl ketone [un1157] [flammable liquid] |
diisobutylketon |
v52w30h1bu , |
4-01-00-03360 (beilstein handbook reference) |
unii-v52w30h1bu |
ec 203-620-1 |
NCGC00256951-01 |
tox21_303091 |
dtxcid905080 |
dtxsid4025080 , |
cas-108-83-8 |
tox21_202406 |
NCGC00259955-01 |
AKOS005207129 |
2,6-dimethyl-heptan-4-one |
STL163555 |
BBL012214 |
einecs 271-042-7 |
FT-0610689 |
diisobutyl ketone [hsdb] |
cognac heptanone |
sym-diisopropy lacetone |
2,6-dimethyl-4-heptanone [fhfi] |
SCHEMBL36990 |
(iso-c4h9)2co |
un 1157 |
2,6-dimethylheptan-4-one (sum of 2,6-dimethyl-4-heptanone & 4,6-dimethyl-2-heptanone) |
di-isobutyl ketone |
2,6 -dimethyl-4 -heptanone |
W-108711 |
CHEMBL3182186 |
chebi:89195 , |
mfcd00008940 |
fema 3537 |
diisopropylacetone |
2,6-dimethyl-4-heptanone (diisobutyl ketone) |
4-heptanone,2,6-dimethyl diisobutyl,ketone |
2,5-dimethyl-4-heptanone |
VS-03235 |
Q2416556 |
F93016 |
2,6-dimethyl-4-heptanone(diisobutyl ketone) |
EN300-19773 |
diisobutylketone-13c4 |
2,6-dimethyl-4-heptanone, tech grade |
Excerpt | Reference | Relevance |
---|---|---|
" Quantitative analysis of DIBC, DIBK, DIBC-alcohol, and DIBK-alcohol in blood samples collected from 5min to 120h after single dosing indicated the following: (1) DIBC and DIBK are both well absorbed following oral gavage with substantial evidence of enterohepatic recirculation of DIBK, DIBC, DIBK-alcohol, and DIBC-alcohol; (2) DIBK and DIBC are interconverted metabolically in rats; (3) DIBC and DIBK have similar bioavailability after oral administration; (4) higher systemic exposure was found for DIBK-alcohol than DIBC-alcohol, implying that DIBC-alcohol may be more easily conjugated and eliminated in bile." | ( Comparative metabolism and pharmacokinetics of diisobutyl ketone and diisobutyl carbinol in male SD rats. Ball, NS; Bartels, MJ; Clark, AJ; Hughes, BJ; Lardie, TS; Markham, DA; Staley, JL; Zhang, F, 2015) | 0.67 |
Excerpt | Relevance | Reference |
---|---|---|
" Dosing was via single oral gavage dosing in male SD rats, followed by blood collection, metabolite identification, major biomarker quantitation, and pharmacokinetics analysis." | ( Comparative metabolism and pharmacokinetics of diisobutyl ketone and diisobutyl carbinol in male SD rats. Ball, NS; Bartels, MJ; Clark, AJ; Hughes, BJ; Lardie, TS; Markham, DA; Staley, JL; Zhang, F, 2015) | 0.67 |
Class | Description |
---|---|
ketone | A compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H). |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 33.7549 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 62.2865 | 0.0008 | 17.5051 | 59.3239 | AID1159527 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 18.4348 | 0.0002 | 29.3054 | 16,493.5996 | AID743075; AID743077; AID743079 |
peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 61.6524 | 0.0010 | 24.5048 | 61.6448 | AID743215 |
Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 100.7150 | 0.0391 | 47.5451 | 146.8240 | AID1224845 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (41.81) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (12.50%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |